
PhaSER receives $2.7 million to grow company
Biotechnology company PhaSER Biomedical has received $2.7 million from the Gates Foundation as part of a two-year grant renewal. The Scottish-based company will use the funding to support the discovery of new treatments targeting some of the world’s most neglected diseases. The funding continues PhaSER’s… Read More














